Cinnamyl isobutyrate

Butyl isovalerate

Hexyl benzoate

Butyl octanoate

Ethyl 2-[[2-methyl-8-[[(4-methylphenyl)sulfonyl]amino]-6-quinolinyl]oxy]acetate (ACI)

Ethyl 9H-xanthene-9-carboxylate (ACI)

Acetic acid, 2-(4-chlorophenoxy)-, ethyl ester (ACI)

Ethyl 1-(phenylmethyl)-4-piperidinecarboxylate (ACI)

Ethyl 10,11-dihydro-4-methoxydibenz[b,f][1,4]oxazepine-8-carboxylate (ACI)

L-Alanine, (4S)-4-ethyl-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-4-yl ester, mono(trifluoroacetate), reaction products with polyethylene glycol bis(carboxymethyl) ether

Poly(oxy-1,2-ethanediyl), α-[(9R)-6-hydroxy-6-oxido-1,12-dioxo-9-[(1-oxotetradecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphapentacos-1-yl]-ω-methoxy-, sodium salt (1:1) (ACI)

Ethyl 2,4-dihydroxybenzoate

Curdlan (9CI, ACI)

Motilin (9CI, ACI)

Anisomelic acid

Isopropylmethylphenol

Galiximab

Immunoglobulin G1, anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal ADG126 γ1-chain), disulfide with prodomain peptide (synthetic masking moiety and protease-cleavable moiety) fusion protein with human monoclonal ADG126 κ-chain, dimer (ACI)

Immunoglobulin IgG1 Fab fragment, anti-(human and Macaca fascicularis transferrin receptors type 1) (human-Mus musculus monoclonal F5298 γ1-chain), disulfide with human-Mus musculus monoclonal F5298 κ-chain (ACI)

Immunoglobulin G4 [226-proline], anti-(human tumor necrosis factor receptor TNFRSF9) (human monoclonal ATOR-1017 γ4-chain), disulfide with human monoclonal ATOR-1017 κ-chain, dimer (ACI)